Overview

Less Sticking.3,‡ Less Buildup.3,† More Efficient Procedures.3,§

Nonstick nano-coating technology enhances the performance of the LigaSure™ Maryland jaw device.

The multifunctional LigaSure™ Maryland jaw device now delivers even greater procedural efficiency.2,3,§

Because — compared to the legacy device — the new nonstick nano-coated jaws:

  • Reduce eschar buildup3,†
  • Decrease instances of sticking4,
  • Lead to fewer jaw cleanings — and make cleanings easier3,§

So you get these benefits in addition to the performance you expect from the LigaSure™ Maryland jaw device.

LigaSure™ Vessel Sealing Technology

Learn more about the technology behind the products.

Learn More 

Features

Enhanced Dissection.5,Ω  Intuitive Control.5,†† Greater Efficiency.3,‡‡

Every feature of the nonstick nano-coated LigaSure™ Maryland jaw device is designed to benefit you and patients.

We engineered our multifunctional LigaSure™ Maryland jaw device to provide efficiency throughout the procedure.6,§§ Now, we’ve taken that efficiency to the next level — by putting nonstick nano-coating on the jaws.3,‡‡

Multifunctional flexibility

With the LigaSure™ Maryland jaw device you get the benefits of:

  • A one-step vessel sealer2
  • A Maryland dissector for enhanced blunt dissection5,Ω Ω
  • An atraumatic grasper to securely grasp tissue5,Ω Ω
  • Cold scissors to leave the critical decision to cut in your hands2,6

Multifunctional performance

The LigaSure™ Maryland jaw device delivers:

  • Improved access compared to straight jaws6,††
  • Improved tip visualization compared to straight jaws6,†††
  • A jaw designed to follow the curvature of the uterus or stomach6,†††
  • Easy skeletonization of vessels6,†††
  • A nonstick nano-coating for improved efficiency6,‡‡

Three lengths to meet different procedural needs

The LigaSure™ Maryland jaw device is available in three lengths:

23 cm

37 cm

44 cm

/content/dam/covidien/library/global/en/product/vessel-sealing/ligasure-maryland-jaw-front-tip-f.jpg

Order Information

Order Information
Order Code Description Length Unit of Measure Quantity
LF1923 Open Sealer/Divider 23 cm Case 6
LF1937 Laparoscopic Sealer/Divider 37 cm  Case 6
LF1944 Laparoscopic Sealer/Divider 44 cm  Case 6
Specifications
Length Rotation Jaw Design Seal Plate Length Cut Length Generator Compatibility
23, 37, and 44 cm 350 degrees Curved 20.3 18.5 Valleylab™ FT10 energy platform, Valleylab™ LS10 energy
platform (where available), and ForceTriad™ energy platform

TECHNOLOGY

Reliable Performance. Greater Efficiency.2,§

We added nonstick nano-coating technology on the LigaSure™ Maryland jaw device to help you tackle challenges both big and small.

The new LigaSure™ Maryland jaw device is designed to help you treat patients — reliably and efficiently.2,§

Because we combined the benefits of nonstick nano-coating technology with the proven performance of LigaSure™ vessel-sealing technology.

Nano-coating is a highly controlled, thin-film coating with uniform thickness. It covers the entire jaws of a LigaSure™ device without impacting the intelligent vessel-sealing algorithms of Valleylab™ energy platforms.

Reduce sticking3,‡ improve efficiency2,§

For the LigaSure™ Maryland jaw device, compared to its uncoated counterpart, that means: 

  • Less eschar buildup3,†
  • Less sticking4,‡
  • Fewer jaw cleanings3,§

The net benefit is smoother, more efficient procedures.3,§

The confidence of control and consistency

LigaSure™ technology has been setting the standard of care for vessel sealing for nearly two decades.

LigaSure™ technology uses the body’s own collagen and elastin to create a permanent seal that can withstand three times normal systolic blood pressure.7 It’s been used in more than 19 million procedures worldwide.8,‡‡‡  And is supported by an ever-growing body of clinical evidence.

With an average seal cycle of one to four seconds in most surgical situations,9 LigaSure™ technology can seal vessels up to and including 7 mm, lymphatics, and tissue bundles. It also eliminates the guesswork — and minimizes thermal spread10 — by automatically discontinuing energy delivery when the seal cycle is complete.9

Made even better by the Valleylab™ FT10 energy platform

The LigaSure™ Maryland jaw portfolio works great when powered by the ForceTriad™ energy platform with 3.6 software and higher. For optimal performance, use it with the Valleylab™ FT10 energy platform.

The Valleylab™ FT10 energy platform makes LigaSure™ devices better than ever.9,11

  • † Eschar buildup assessed using optical imaging analysis after 60 seal and divide cycles.

  • ‡ Instances of tissue sticking to jaws measured over 110 seals per device.

  • § Cleaning effectiveness assessed after each of two cleaning cycles.

  • Ω When compared to the surgeon’s primary device, 23 out of 32 surveyed agreed.

  • †† 31 out of 33 surgeons surveyed agreed.

  • ‡‡ Compared to the legacy device. Cleaning effectiveness assessed after each of two cleaning cycles.

  • §§ 32 out of 32 surgeons surveyed agreed.

  • ΩΩ 33 out of 33 surgeons surveyed agreed.

  • ††† 30 out of 33 surgeons surveyed agreed.

  • ‡‡‡ Based on data from 2001 through FY17.

  • 1. Refer to IFU for full list of product indications for use

  • 2. LigaSure™ Maryland Jaw Sealer/Divider, Nano-Coated [instructions for use]. Boulder, CO: Medtronic; 2016.

  • 3. Based on internal test report #RE00071599, LF19XX MJC marketing claims report conducted on porcine tissue. Feb. 7 to Feb. 22, 2017.

  • 4. Based on internal test report #RE00073194 , Tissue sticking comparison of the Ethicon G2™*, Voyant™* 5 mm Fusion, LigaSure™ LF1737, and LigaSure™ LF1937 devices conducted on porcine tissue using the Force Triad™ energy platform. Jan. 18, 2017.

  • 5. Based on internal test report #R0035742, Maryland validation labs: Independent surgeon feedback collected during porcine labs in Houston and Los Angeles. April 16 to 18 and April 30 to May 3, 2013.

  • 6. Based on internal test report #RE00071598, Maryland validation labs: Independent surgeon feedback collected during porcine labs in Houston and Los Angeles. April 16 to 18 and April 30 to May 3, 2013.

  • 7. Based on internal test report #RE00070396 Rev A, Verification of the LF1923/LF1937/LF1944 Maryland devices in a renal bench burst study: iterations Maryland. Nov. 7–10, 2016.

  • 8. Based on internal test report #R0064457, LigaSure™ device renal bench burst pressure evaluation of the Valleylab™ FT10 energy platform. May 3, 2015.

  • 9. Based on internal report #US161132(1), Sales data from FY01 to FY17. July 2017.

  • 10. Based on internal test report #RE00025819 Rev A, LigaSure™ device data sources for VLFT10 white papers. September 2015.

  • 11. Based on internal test report #RE00005503, Verification report: GLP acute animal lab: LigaSure™ device preclinical evaluation of Valleylab™ FT10 energy platform. May 19, 2015.

  • 12. Based on internal test report #RE00005401 Rev A, Product validation of Valleylab™ FT10 energy platform: surgeon and nurse evaluation in simulated use. Jan. 27 to 30, 2015 and Feb. 24 to 27, 2015.

Provide details to continue

  • Your information will be protected in accordance with our privacy statement.

The site needs to use cookies to store information in your web browser, to make this site work. By clicking “Submit” you consent to the placement of these cookies. Learn more about our cookie policy.